Sonnet BioTherapeutics Inc. (SONN) Revenue Analysis | Historical Sales Growth & Trends - Stocknear

Sonnet BioTherapeutics I...

NASDAQ: SONN · Real-Time Price · USD
2.85
-0.05 (-1.72%)
At close: Sep 05, 2025, 3:59 PM
2.98
4.56%
After-hours: Sep 05, 2025, 06:34 PM EDT

Sonnet BioTherapeutics Revenue

Sonnet BioTherapeutics reported an annual revenue of $18.63K, reflecting a -87.4% growth. For the quarter ending June 30, 2025, Sonnet BioTherapeutics generated $0 in revenue.
Revenue (ttm)
18.63K
Revenue Growth
-87.4%
Price / Sales Ratio
235.35
Revenue / Employee
1.43K
Employees
13
Market Cap
19.08M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sep 30, 2024 18.63K -87.40%
Sep 30, 2023 147.81K -57.76%
Sep 30, 2022 349.94K -27.64%
Sep 30, 2021 483.63K +Infinity%
Sep 30, 2020 0 -100.00%
Sep 30, 2019 40.61M +32.15%
Dec 31, 2018 30.73M -25.82%
Dec 31, 2017 41.43M -0.65%
Dec 31, 2016 41.7M -1.64%
Dec 31, 2015 42.4M +Infinity%
Dec 31, 2014 0 -100.00%
Dec 31, 2013 17.5M +154.20%
Dec 31, 2012 6.88M +370.21%
Dec 31, 2011 1.46M +973.96%
Dec 31, 2010 136.3K -80.09%
Dec 31, 2009 684.67K +192.53%
Dec 31, 2008 234.06K n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.